Cooperation

$ 40 billion

Estimated CAR-T market value by 2032

96 %

Malignant cancers are solid tumors

18 million

New cancer cases annually

Discover the details of our investment collaboration and the benefits of investing in our company in a Q&A with Paweł Wiśniewski, CEO of 4Cell Therapies. Click below to learn more about our investment offer and strategic plans for the future.

Why CAR-T?

The CAR-T therapy market is growing rapidly, offering significant opportunities for investors. The global CAR-T market is projected to expand from $4.5 billion in 2023 to $39.9 billion by 2032, with an impressive compound annual growth rate (CAGR) of 27.5%. This growth is driven by the rising incidence of cancer and advancements in genetic engineering technologies, such as CRISPR, which are making CAR-T therapies increasingly effective and accessible.

Kite Pharma: Acquired by Gilead Sciences for $11.9 billion in 2017.
Juno Therapeutics: Acquired by Celgene for $9 billion in 2018.
Bluebird Bio: Gene therapy division acquired by Bristol-Myers Squibb for $13.1 billion in 2019.
Adaptimmune Therapeutics: Partnership with Astellas Pharma valued at up to $897 million in 2020.
Allogene Therapeutics: Listed on NASDAQ with a valuation of $324 million in 2018.

How to Invest?

The investment process in 4Cell Therapies is simple and transparent:

1. Contact the Investment Department: Reach out for detailed information on current investment opportunities.

Phone: +48 571505139
Email: inwestycje@4celltherapies.com

2. Information Meeting: Schedule a meeting to discuss investment opportunities, development plans, and financial forecasts.

3. Sign the Investment Agreement: After reviewing the offer, the investor signs the agreement and deposits capital.

4. Transaction Confirmation: Upon deposit, the investor receives confirmation and documentation of share ownership.

5. Ongoing Contact and Updates: Investors have regular access to company updates, financial reports, and participation in shareholder meetings.

Contact Us

If you are interested in investing in 4Cell Therapies and want to learn more about our investment opportunities, feel free to reach out. Our specialists will be happy to answer any questions and provide details about our investment offer.

Contact:

Phone: +48 571505139
Email: inwestycje@4celltherapies.com